Tandem Diabetes Care Inc (NASDAQ: TNDM) kicked off on Tuesday, up 10.92% from the previous trading day, before settling in for the closing price of $20.23. Over the past 52 weeks, TNDM has traded in a range of $15.75-$49.71.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 21.01%. While this was happening, its average annual earnings per share was recorded 6.88%. With a float of $65.98 million, this company’s outstanding shares have now reached $66.57 million.
Let’s determine the extent of company efficiency that accounts for 2650 employees. In terms of profitability, gross margin is 46.57%, operating margin of -16.18%, and the pretax margin is -15.82%.
Tandem Diabetes Care Inc (TNDM) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Tandem Diabetes Care Inc is 0.95%, while institutional ownership is 110.38%. The most recent insider transaction that took place on Mar 07 ’25, was worth 190,966. In this transaction EVP & Chief Operating Officer of this company bought 10,538 shares at a rate of $18.12, taking the stock ownership to the 10,538 shares. Before that another transaction happened on Nov 21 ’24, when Company’s Director sold 30,000 for $31.38, making the entire transaction worth $941,400. This insider now owns 165,190 shares in total.
Tandem Diabetes Care Inc (TNDM) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 6.88% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 70.64% during the next five years compared to -28.23% drop over the previous five years of trading.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Trading Performance Indicators
Take a look at Tandem Diabetes Care Inc’s (TNDM) current performance indicators. Last quarter, stock had a quick ratio of 1.81. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.78, a number that is poised to hit -0.39 in the next quarter and is forecasted to reach -0.64 in one year’s time.
Technical Analysis of Tandem Diabetes Care Inc (TNDM)
Looking closely at Tandem Diabetes Care Inc (NASDAQ: TNDM), its last 5-days average volume was 1.39 million, which is a drop from its year-to-date volume of 1.56 million. As of the previous 9 days, the stock’s Stochastic %D was 58.43%. Additionally, its Average True Range was 1.10.
During the past 100 days, Tandem Diabetes Care Inc’s (TNDM) raw stochastic average was set at 30.16%, which indicates a significant decrease from 72.13% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 72.18% in the past 14 days, which was lower than the 89.99% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $19.73, while its 200-day Moving Average is $30.30.
